CD11c/CD18 Dominates Adhesion of Human Monocytes, Macrophages and Dendritic Cells over CD11b/CD18

Noémi Sándor1, Szilvia Lukácsi2, Rita Ungai-Salánki3

  • 1MTA-ELTE Immunology Research Group, Hungarian Academy of Sciences, Budapest, Hungary.

Plos One
|September 23, 2016
PubMed

Insights

Complement receptors CD11b/CD18 (CR3) and CD11c/CD18 (CR4) mediate cell adhesion. CD11c dominates fibrinogen binding, with CD11b competition influencing myeloid cell attachment.

Area of Science:

  • Immunology
  • Cell Biology
  • Biophysics

Background:

  • Complement receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18) are beta2 integrins expressed on human myeloid cells.
  • Previous research indicated CR3's primary role in phagocytosis over CR4.
  • Fibrinogen is a common ligand for both CR3 and CR4.

Purpose of the Study:

  • To investigate the distinct roles of CD11b and CD11c in cell adhesion to fibrinogen.
  • To quantify CD11b and CD11c expression levels on human monocytes, macrophages (MDMs), and dendritic cells (MDDCs).
  • To elucidate the functional interplay between CD11b and CD11c in mediating cell-fibrinogen interactions.

Main Methods:

  • Bead-based technique for quantifying CD11b and CD11c surface expression.
  • State-of-the-art biophysical techniques to measure cellular adhesion strength.
  • Blocking studies using antibodies against CD11b to assess its inhibitory effect on adhesion.

Main Results:

  • CD11c expression is preponderant in MDDCs, while CD11b is more dominant in monocytes.
  • Cellular adhesion to fibrinogen is primarily mediated by CD11c.
  • Blocking CD11b significantly enhanced MDDC and MDM attachment to fibrinogen, revealing competitive binding.

Conclusions:

  • CD11c plays a dominant role in the adhesion of myeloid cells to fibrinogen.
  • A competitive interaction exists between CD11b and CD11c for fibrinogen binding.
  • A model was developed explaining differential cell adhesion behavior based on receptor numbers and binding strength.